• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON AND CO. BD ULTRA FINE¿ INSULIN PEN NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON AND CO. BD ULTRA FINE¿ INSULIN PEN NEEDLE Back to Search Results
Catalog Number 320122
Device Problems Fluid/Blood Leak (1250); Application Program Problem: Medication Error (3198)
Patient Problems Hyperglycemia (1905); Underdose (2542)
Event Date 02/16/2018
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that several bd ultra fine¿ insulin pen needle(s) leaked during use, resulting in incorrect dosage and elevated blood sugar for the consumer.There was no report of serious injury or medical interventions.
 
Manufacturer Narrative
Investigation results: severity: s2; occurrence: a complaint history check was performed and this is the 1st related complaint reported for the defects/conditions on lot number 7256602.Customer returned ( 7 ) sealed 4mm, 32g bd pen needles.Consumer states the needles are leaking resulting in elevated blood sugar.All returned pen needles were tested for flow as well as for point geometry, outer diameter and lube coverage.The following was observe: data: point (pe/npe) outer diameter (in) lube sample 1: good/good, 0.0091, good.Sample 2: good/good, 0.0092, good.Sample 3: good/good, 0.0092, good.Sample 4: good/good, 0.0091, good.Sample 5: good/good, 0.0091, good.Sample 6: good/good, 0.0090, good.Sample 7: good/good, 0.0092, good.Leakeage was not observed on any of the returned and tested samples; the alleged deffect could not be confirmed.A lot history review was carried out and no related non conformances were raised in association with this packaged lot concluding all inspections were performed per the applicable operations and met qc specifications.Based on the samples / photo(s) received the investigation concluded: unconfirmed: bd was not able to duplicate or confirm the customer¿s indicated failure.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Root cause cannot be determined at this time as the issue is unconfirmed.Based on the investigation, no additional investigation and no capa is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ULTRA FINE¿ INSULIN PEN NEEDLE
Type of Device
PEN NEEDLE
Manufacturer (Section D)
BECTON DICKINSON AND CO.
pottery road
dun laoghaire co
MDR Report Key7397709
MDR Text Key104537083
Report Number9616656-2018-00079
Device Sequence Number1
Product Code FMI
UDI-Device Identifier10885403928659
UDI-Public10885403928659
Combination Product (y/n)N
PMA/PMN Number
K162516
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup
Report Date 04/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number320122
Device Lot Number7256602
Initial Date Manufacturer Received 02/16/2018
Initial Date FDA Received04/04/2018
Supplement Dates Manufacturer Received02/16/2018
Supplement Dates FDA Received04/11/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-